journal article·2026-03Open access

A pH-responsive Chitosan/PEGDA composite hydrogel encapsulating dihydromyricetin ZIF-8 nanoparticles for infarcted myocardial repair by inhibiting ferroptosis

Tianhu Wang, Yingjie Zhang, Sijia Chen, Naiyuan Sun, Tingting Lu, Linghuan Wang, Jin Yan, Yifan Wang, Cheng Qin, Yan Ma, Yujia Wang, Huijia Yin, Jing Liu, Xiaoying Shen, Na Kang, Feng Cao

Abstract

Cardiomyocyte loss is substantial after myocardial infarction (MI). Given the heart's limited intrinsic regenerative capacity, this loss frequently triggers myocardial fibrosis, detrimental ventricular remodeling, and ultimately culminates in heart failure. Among post-MI cell death pathways, cardiomyocyte ferroptosis—driven by ischemia, hypoxia, and oxidative stress—is a major contributor. Here, we constructed a novel pH-responsive anti -ferroptotic hydrogel for MI repair: a chitosan/PEGDA composite hydrogel encapsulating dihydromyricetin (DHM)-laden zeolitic imidazolate framework-8 (ZIF-8) nanoparticles (ZIF-8@DHM NPs), denoted as ZIF-8@DHM/CP hydrogel. In vitro investigations demonstrated that the ZIF-8@DHM/CP hydrogel exhibited remarkable reactive oxygen species (ROS) scavenging capacity and successfully mitigated ferroptosis in H9C2 cells via the Sirt1/Nrf2/GPX4 pathway. We investigated the in vivo effects of ZIF-8@DHM/CP hydrogel utilizing a rat MI model. After injection for 28 days, the ZIF-8@DHM/CP hydrogel markedly enhanced cardiac function recovery in infarcted rats compared to the PBS group (left ventricular ejection fraction increased from 28.17 ± 2.94% to 52.35 ± 5.79%, P < 0.05), and histological analysis showed significant preservation of left ventricular free wall thickness in the ZIF-8@DHM/CP hydrogel group (thickness increased from 0.67 ± 0.15 mm to 1.50 ± 0.18 mm, P < 0.05). The results demonstrated that the ZIF-8@DHM/CP hydrogel prevented ferroptosis in cardiomyocytes, exhibited ROS-scavenging and anti-inflammatory properties, enhanced recovery of cardiac function post-MI, and prevented unfavorable remodeling. In this study, we enhanced the mechanical properties of a chitosan hydrogel and imparted anti -ferroptosis activity by constructing a composite drug-loaded hydrogel, providing a new perspective and direction for using chitosan hydrogel to promote MI repair. Schematic illustration of the fabrication of ZIF‑8@DHM/CP hydrogel and its repair mechanism in myocardial infarction. • Novel MOF-based pH-responsive hydrogel targets cardiomyocyte ferroptosis for myocardial infarction therapy. • It inhibits ferroptosis via Sirt1/Nrf2/GPX4 pathway and elevates EF to 52.35% in infarcted rats. • The system attenuates post-MI cardiac remodeling and preserves ventricular wall integrity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ferroptosis and cancer prognosis · Cardiac Fibrosis and Remodeling · GDF15 and Related Biomarkers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (58)

Show source-provided references
1. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 201910.1016/S0140-6736(20)30752-2 ↗
2. (+)-JQ-1 alleviates cardiac injury in myocardial infarction by inhibiting ferroptosis through the NAMPT/SIRT1 pathway10.1038/s41419-025-07880-x ↗
3. Heart regeneration by endogenous stem cells and cardiomyocyte proliferation: controversy, fallacy, and progress10.1161/CIRCULATIONAHA.119.045566 ↗
4. Regulated cell death in acute myocardial infarction: molecular mechanisms and therapeutic implications10.1016/j.arr.2024.102629 ↗
5. EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis10.1016/j.phymed.2023.154999 ↗
6. Ferroptosis: opportunities and challenges in myocardial ischemia-reperfusion injury
7. Adaptor protein HIP-55-mediated signalosome protects against ferroptosis in myocardial infarction10.1038/s41418-022-01110-z ↗
8. Myocardial regeneration: present and future trends10.2165/00129784-200101040-00002 ↗
9. Oxygen delivery approaches to augment cell survival after myocardial infarction: progress and challenges10.1007/s12012-021-09696-5 ↗
10. Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches10.1016/j.phrs.2024.107281 ↗
11. The role of hydrogel in cardiac repair and regeneration for myocardial infarction: recent advances and future perspectives
12. Light-triggered drug release from 3D-Printed magnetic chitosan microswimmers10.1021/acsnano.8b05997 ↗
13. Fabrication and characterization of 3D printed agarose/poly(ethylene glycol) diacrylate/hydroxyapatite nanocomposite hydrogel for cartilage tissue engineering
14. Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease10.1016/j.biopha.2021.111927 ↗
15. Dihydromyricetin attenuates diabetic cardiomyopathy by inhibiting oxidative stress, inflammation and necroptosis via Sirtuin 3 activation10.3390/antiox12010200 ↗
16. Dihydromyricetin attenuates cerebral ischemia reperfusion injury by inhibiting SPHK1/mTOR signaling and targeting ferroptosis10.2147/DDDT.S378786 ↗
17. Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis10.1016/j.taap.2023.116595 ↗
18. Dihydromyricetin inhibits ferroptosis to attenuate cisplatin-induced muscle atrophy10.33549/physiolres.935317 ↗
19. Recent update on the pharmacological effects and mechanisms of dihydromyricetin10.3389/fphar.2018.01204 ↗
20. Reticular synthesis and the design of new materials10.1038/nature01650 ↗
21. Drug-delivery nanoplatform with synergistic regulation of angiogenesis-osteogenesis coupling for promoting vascularized bone regeneration10.1021/acsami.2c23107 ↗
22. Design of a Zn-based nanozyme injectable multifunctional hydrogel with ROS scavenging activity for myocardial infarction therapy10.1016/j.actbio.2024.01.015 ↗
23. pH-responsive biomimetic zeolitic imidazolate framework-based nanoparticles for co-delivery of cetuximab and siRNA in synergistic therapy of laryngeal squamous cell carcinoma10.1016/j.jpha.2025.101203 ↗
24. Surfactant concentration and pH effects on the zeta potential values of alumina nanofluids to inspect stability10.1016/j.colsurfa.2019.123960 ↗
25. Bioactive peptide-based composite hydrogel for myocardial infarction treatment: ROS scavenging and angiogenesis regulation10.1016/j.actbio.2025.03.035 ↗
26. Eco-friendly and facile synthesis of antioxidant, antibacterial and anticancer dihydromyricetin-mediated silver nanoparticles10.2147/IJN.S283677 ↗
27. Pro-apoptotic effect of zeolitic imidazolate Framework-8 (ZIF-8)-Loaded dihydromyricetin on HepG2 cells10.3390/molecules27175484 ↗
28. A multifunctional chitosan hydrogel dressing for liver hemostasis and infected wound healing10.1016/j.carbpol.2022.119631 ↗
29. Bioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine10.1016/j.progpolymsci.2013.12.001 ↗
30. 3D-printed poly(ethylene) glycol diacrylate (PEGDA)-chitosan-nanohydroxyapatite scaffolds: structural characterization and cellular response10.1016/j.ijbiomac.2025.139652 ↗
31. Photocrosslinkable and self-healable hydrogels of chitosan and hyaluronic acid10.1016/j.ijbiomac.2022.07.004 ↗
32. Synthesis and characterization of polymer-based coatings modified with bioactive ceramic and bovine serum albumin10.3390/jfb12020021 ↗
33. Bacterial cellulose reinforced chitosan-based hydrogel with highly efficient self-healing and enhanced antibacterial activity for wound healing10.1016/j.ijbiomac.2022.07.017 ↗
34. Melatonin engineering M2 macrophage-derived exosomes mediate endoplasmic reticulum stress and immune reprogramming for periodontitis therapy
35. Regeneration of infarcted hearts by myocardial infarction-responsive injectable hydrogels with combined anti-apoptosis, anti-inflammatory and pro-angiogenesis properties10.1016/j.biomaterials.2022.121849 ↗
36. Advancing preclinical drug evaluation: assessing drug-loaded metal-organic frameworks in droplet-based microfluidics for prostate cancer treatment10.1016/j.mtadv.2025.100618 ↗
37. Drug-loaded mesoporous polydopamine nanoparticles in chitosan hydrogels enable myocardial infarction repair through ROS scavenging and inhibition of apoptosis10.1021/acsami.4c08155 ↗
38. Multi-stage cooperative ROS-responsive hydrogel platform for drug delivery in myocardial ischemia-reperfusion injury repair
39. Xanthosine alleviates myocardial ischemia-reperfusion injury through attenuation of cardiomyocyte ferroptosis10.1186/s11658-025-00766-y ↗
40. Rg3-loaded P407/CS/HA hydrogel inhibits UVB-induced oxidative stress, inflammation and apoptosis in HaCaT cells10.1016/j.biopha.2023.115177 ↗
41. Targeting ferroptosis by polydopamine nanoparticles protects heart against Ischemia/Reperfusion Injury10.1021/acsami.1c18061 ↗
42. Role of GPX4 in ferroptosis and its pharmacological implication
43. GPX4 in cell death, autophagy, and disease10.1080/15548627.2023.2218764 ↗
44. RGD-modified ZIF-8 nanoparticles as a drug carrier for MR imaging and targeted drug delivery in myocardial infarction10.1080/17435889.2024.2365623 ↗
45. Baicalin-loaded Polydopamine modified ZIF-8 NPs inhibits myocardial ischemia/reperfusion injury in rats10.1080/09205063.2024.2358640 ↗
46. Apoptosis and myocardial infarction10.1007/s003950050195 ↗
47. miR-30e-5p alleviates inflammation and cardiac dysfunction after myocardial infarction through targeting PTEN10.1007/s10753-020-01376-w ↗
48. Dihydromyricetin ameliorates cardiac Ischemia/Reperfusion Injury through Sirt3 activation10.1155/2019/6803943 ↗
49. Nanosponge for iron chelation and efflux: a ferroptosis-inhibiting approach for myocardial infarction therapy
50. Junctophilin-2 regulates store-operated calcium entry to drive cardiac fibroblast activation, fibrotic repair, and angiogenesis after myocardial infarction10.1161/CIR.0000000000001398 ↗
51. Bioactive peptide-based electroactive hydrogels for myocardial infarction treatment via electrical and microenvironmental regulation10.1021/acsami.5c06438 ↗
52. Hydrogel loaded with peptide-containing nanocomplexes: symphonic cooperation of photothermal antimicrobial nanoparticles and prohealing peptides for the treatment of infected wounds10.1021/acsami.3c16061 ↗
53. A cyclic heptapeptide-based hydrogel boosts the healing of chronic skin wounds in diabetic mice and patients10.1038/s41427-022-00444-x ↗
54. ROS scavenging activity of polydopamine nanoparticle-loaded supramolecular gelatin-based hydrogel promoted cardiomyocyte proliferation
55. Chitosan based film reinforced with EGCG loaded melanin-like nanocomposite (EGCG@MNPs) for active food packaging10.1016/j.carbpol.2022.119471 ↗
56. Injectable Fullerenol/Alginate hydrogel for suppression of oxidative stress damage in brown adipose-derived stem cells and cardiac repair10.1021/acsnano.7b00221 ↗
57. Microenvironment-regulated hydrogels prepared with a brand-new small molecule cross-linker for stepwise treatment of myocardial infarction10.1002/adhm.202500804 ↗
58. Bioinspired conductive structural color hydrogels: a theragnostic platform for spatiotemporal monitoring and repair of myocardial infarction10.1002/adfm.202510548 ↗